![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, August 21, 2013 9:45:57 AM
The only thing propping up the stock price at the moment is "hope." Hope that something "magical" will happen in the next few months, based on existing P3 trial data. Well folks, that data has already been sliced and diced. There is nothing else to learn from it.
A new (confirmatory) trial will be needed (at least by the FDA), and the CEO mentioned that during the last conference call.
As for Hisun and the CFDA, that's the only real positive wildcard left out there. And it's a longshot at best whether TDOX can be commercialized based on a failed P3 trial in China.
The ONLY short-term hope for investors is if the subgroup cohort showing the best results actually came from Chinese patient. Remember, there were only (15) U.S. patients in the entire trial!
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM